New Kinase Inhibitor Effective against Drug-Resistant Leukemia, Preclinical Study Finds March 31, 2016 By Dottie Forthman March 21, 2016 By Laura Oleniacz, UNC Lineberger Comprehensive Cancer Center Read the entire article here The investigational compound MRX-2843 is shown in green on the active site of the MERTK protein. . Comments are closed.
